Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sirolimus

EU orphan designation number: EU/3/13/1204   
Active ingredient: Sirolimus
Indication: Prevention of arteriovenous access dysfunction in patients undergoing surgical creation of an arteriovenous access for haemodialysis
Sponsor: S-cubed Ltd
99 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan Designation EMA/OD/117/13 (2013)8051 of 13/11/2013